AGORACOM News Flash

AGORACOM CONFERENCE UPDATE

12 More Companies Added To Schedule For Dec 3 & 4. (See Schedule)
Keynote Speakers Include Peter Grandich, Eric Coffin (See Speakers)
Workshop Presentations Added To Thursday Schedule
Investors from over 45 Countries Have Visited
Conference Begins 2 Weeks From Today!

Looking forward to seeing all of you there gang. Registration is free for investors. AGORACOM Members register with just one click. Non-members takes less than 60 seconds. Register here (see form on right hand side)

Message: NEWS - Leadership Strength for ProtoKinetix

AGORACOM

Rank: [?]

President

Points: [?]

11204

Rating: [?]

Votes: 29 Score: 4.0

Currently 4.0/5 Stars.

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

NEWS - Leadership Strength for ProtoKinetix

posted on Aug 09, 07 03:00AM

VANCOUVER, British Columbia, Aug 09, 2007 -- ProtoKinetix Inc.'s (OTCBB:PKTX) Board of Directors is pleased to announce the appointment of Ross L. Senior, LLB as its President and CEO.

Mr. Senior brings a wide range of corporate and executive management experience in technology research and business development. He specializes in building relationships between technology developers and corporate consumers.

Previously, Ross Senior was a Chairman of the Canadian Advanced Technology Association and co-founded a high-end skin care company. ProtoKinetix' Board of Directors enthusiastically looks forward to working with Mr. Senior to further the commercialization of the family of AAGP(TM) molecules.

Board member Dr. Max Arella commented, "Ross brings an excellent blend of technology background as well as building experience and corporate leadership qualities. He will be a welcome addition to ProtoKinetix management team.";

About ProtoKinetix:

ProtoKinetix Inc. is a Biotechnical Company that has developed and patented a family of synthetic antifreeze glycoproteins (AAGP(TM)) for human and veterinary medicine, the pharmaceutical and cosmetic industries. Using previously published research on native antifreeze proteins and antifreeze glycoproteins as a guide, and coordinating a vast pool of world recognized intellectual talent in a networked environment, PKTX is currently negotiating commercial and collaborative agreements on several of the proven and tested applications. Sign up for free automatic email news alerts at our new website at: www.protokinetix.com

The Private Securities Litigation Reform Act of 1995 provides a "safe harbor" for forward-looking statements. Some information included in this press release contains statements that are forward-looking. Such forward-looking information involves significant risks and uncertainties that could affect anticipated results in the future and, accordingly, these results may differ materially from those expressed in any forward-looking statements made by or on behalf of the Company. For a description of additional risks and uncertainties, please refer to the Company's filings with the Securities and Exchange Commission.

On behalf of the Board of Directors Company Office: Suite # 1500 885 West Georgia Street Vancouver, BC V6C 3E8

Investor Contact:
ProtoKinetix Inc.
Blair Henderson,
604-687-9887